Status:
RECRUITING
Prospective Observational Trial to Evaluate Quality of Life After Definitive Chemoradiation in Patients With Anal Cancer (LANACARE)
Lead Sponsor:
Ludwig-Maximilians - University of Munich
Conditions:
Anal Cancer
Quality of Life
Eligibility:
All Genders
18+ years
Brief Summary
Observational study to evaluate longitudinal quality of life according to standardized EORTC questionaires as well as functional outcome, oncological outcome and toxicity in patients treated with defi...
Detailed Description
Observational study to evaluate longitudinal quality of life according to standardized EORTC questionaires as well as functional outcome, oncological outcome and toxicity in patients treated with defi...
Eligibility Criteria
Inclusion
- histologically proven anal cancer without distant metastases
- indication for definitive chemoradiation therapy based on multidisciplinary evaluation
- age \>=18 years
- written informed consent
- ability to answer the standardized questionaires according to the treating physician
Exclusion
- age \< 18 years
- prior systemic therapy with regard to anal cancer
- distant metastases
- second malignancy
Key Trial Info
Start Date :
December 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03792854
Start Date
December 1 2018
End Date
December 1 2026
Last Update
January 3 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Radiation Oncology, University Hospital, LMU Munich
Munich, Bavaria, Germany, 81377